What is Genetica?
Genetica operates as a pioneering technology firm dedicated to addressing complex challenges within the cannabis industry through the deployment of advanced artificial intelligence. At the core of its value proposition is the Flora AI Product Suite, a sophisticated platform designed to provide actionable insights and operational tools for both enterprise-level businesses and end-consumers. By integrating machine learning into the supply chain and consumer experience, Genetica facilitates more efficient market navigation and informed decision-making. The company's focus on high-tech innovation allows it to serve as a vital intermediary in an increasingly regulated and competitive global landscape, ensuring that stakeholders can optimize their workflows and product offerings with precision.
How much funding has Genetica raised?
Genetica has raised a total of $2.5M across 2 funding rounds:
Angel/Seed
$500K
Other Financing Round
$2M
Angel/Seed (2023): $500K with participation from Show Me Organics, Ensemble Investments, Michael Heller, Mitchell Harounian, and Hara Supply
Other Financing Round (2023): $2M led by JAM Fund
Key Investors in Genetica
Ensemble Investments
Ensemble Corporate is a real estate investment firm with over 35 years of experience and $2.1 billion in assets under management, focusing on life science and hospitality sectors. They bring significant expertise in property development and community integration to their strategic investments.
Hara Supply
Hara Supply is a major manufacturer of pre-rolled cones and custom packaging solutions, operating 14 manufacturing sites globally. They serve as a key industry partner, providing essential infrastructure and supply chain support to cannabis organizations.
JAM Fund
JAMFund is a charitable organization established in 2005 that supports children with life-threatening illnesses through various fundraising initiatives and community events.
What's next for Genetica?
With the recent capital infusion, Genetica is poised to scale its Flora AI Product Suite, focusing on deeper integration within the cannabis supply chain and expanding its footprint in key regional markets. The strategic roadmap likely involves enhancing the predictive capabilities of its AI models to better serve the evolving needs of growers, processors, and dispensaries. Furthermore, the company is expected to prioritize talent acquisition and infrastructure development to maintain its competitive edge. As it transitions from its current growth phase toward broader enterprise adoption, Genetica will likely seek to establish further partnerships that leverage its unique data assets to drive industry-wide standardization and efficiency.
See full Genetica company page
